Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Therapeutics, Inc. Announces Clinical and Preclinical Results to be Presented At ASCO; CIBC Holds Investor Call from ASCO.


Business Editors, Health & Medical Writers

SEATTLE--(BW HealthWire)--May 12, 2000

Cell Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (cti) (Nasdaq:CTIC CTIC Conservation Technology Information Center
CTIC Chicago Title Insurance Company
CTIC Centro Tecnológico de la Información y de la Comunicación (Spanish: Center for the Development of Information and Communication Technologies in Asturias) 
) is pleased to announce that the following presenters will be discussing studies of cti products under development at the American Society of Clinical Oncology's (ASCO ASCO American Society of Clinical Oncology
ASCO Association of Schools and Colleges of Optometry (since 1941; Rockville, Maryland)
ASCO Australian Standard Classification of Occupations
ASCO Automatic Switch Company
) 36th Annual Meeting on May 20-23. The meeting will be held at the Ernest N. Morial Convention Center The Ernest N. Morial Convention Center is a collection of buildings in New Orleans, Louisiana. The lower end of building one is located 500 m (1640 feet) upriver from Canal Street on the banks of the Mississippi River. Named after former mayor of New Orleans Ernest N.  in New Orleans New Orleans (ôr`lēənz –lənz, ôrlēnz`), city (2006 pop. 187,525), coextensive with Orleans parish, SE La., between the Mississippi River and Lake Pontchartrain, 107 mi (172 km) by water from the river mouth; founded , Louisiana, at the following locations:


Date/Time            Location          Title          Presenter
----------          ---------          ------        -----------

Sunday, May 21,    Hall E (Main    Clinical and       Steven M.
8:00 a.m.-12 noon  Lobby)          Pharmacologic      Soignet, M.D.
Poster Session                     Study of Arsenic   Memorial

                                   Trioxide (As2O3)   Sloan-Kettering
                                   in Patients with   Cancer Center
                                   Solid Tumors

Sunday, May 21,     R02-03(2nd     As2O3 and          N. J. Bahlis,
1:005:00 p.m.      Floor          Peripheral         M.D.
Discussion          Riverside      Benzodiazepine     University of
4:005:00           Escalators)    Receptor Ligand    Miami
Poster Session                     PK11195
                                   Induced Apoptosis
                                   in Chemoresistant
                                   Multiple Myeloma

Monday, May 22,      R02-03(2d     Phase II Study      Mary L. Keohan,
8:00 a.m.-12 noon    Floor         of CT-2584, a       M.D.
Discussion-          Riverside     Novel Inhibitor of  Columbia
11:00 a.m.-12        Escalators)   Phosphatidylcholine University
noon Poster                        Biosynthesis, in
Session                            Patients with Soft
                                   Tissue Sarcoma

Monday, May 22       E3            Clinical and        Geraldine. A.
1:00 p.m.-5:00 p.m. (Main          Pathological        Goss, M.D.
                     Lobby)        Characteristics of  Dana Farber
                                   Gastrointestinal    Cancer
                                   Stromal Tumors      Institute
                                   (Gist.)

Monday, May 22       B2-2 (Main    Acute Myelogenous   Martin S.
11:00 a.m.-          Lobby)        Leukemia: New       Tallman, M.D.
12:15 p.m.                         Scientific          Northwestern
Education Session                  Discoveries         University
                                   Translating to      Medical School
                                   New Clinical Trials
And repeated on

Tuesday, May 23      E3 (Main Lobby)
9:15 a.m.-10:30 a.m.
Education Session


cti is committed to developing an integrated portfolio of products to make cancer more treatable. The Company's web site is located at www.cticseattle.com.

CIBC CIBC Canadian Imperial Bank of Commerce
CIBC Centres Interinstitutionnels de Bilan de Compétences
CIBC Commonwealth Institute of Biological Control (Trinidad)
CIBC Commercial International Brokerage Company
 INVESTORS CALL

An Investors Call will be held from ASCO on Monday, May 22, 10:30 a.m. CDT/11:30 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
. The call will be hosted by Matthew Geller, Ph.D., Sr. Biotechnology Analyst with CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. . Featured guest will be Steven M. Soignet, M.D., Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New . Dr. Soignet will be reviewing interesting new therapies at ASCO.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 12, 2000
Words:374
Previous Article:North Carolina's Coble Leads Charge into Red Man All-American Final; Bass Anglers Pared to Final-Five for Shot at $100,000.
Next Article:Thermogenesis Corp. Announces Results for the Quarter Ended March 31, 2000.
Topics:



Related Articles
Onyx Pharmaceuticals Reports Second Quarter and Six Months Financial Results.
Cell Therapeutics, Inc. Initiates Second Efficacy Trial of Apra: a New Treatment for Cancer.
Preclinical Studies Show Cell Pathways' Exisulind is Synergistic With Conventional Chemopreventive and Chemotherapeutic Drugs.
AVI BioPharma To Present Promising Clinical Cancer Vaccine Data at Prominent Oncology Conference.
Peregrine Announces Acceptance of Abstract for the American Society of Clinical Oncology; Updated Interim Cotara Phase II Clinical Trial Data For...
AVI BioPharma Scientists To Present Encouraging Phase II Avicine Results at ASCO.
ADVISORY/Phase 3 Studies Suggest Single Dose Of Pegfilgrastim As Effective As Multiple Daily Doses Of Filgrastim In Reducing Neutropenia.
ADVISORY/Amgen's KGF Shows Preliminary Efficacy in Preventing Chemotherapy-Induced Severe Oral Mucositis.
Bayer Yakuhin Files Anti-cancer Drug Nexavar(R) for the Treatment of Advanced Renal Cell Carcinoma.
ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles